Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

US Patent 11197869 · Granted Dec 14, 2021

Estimated economic value: $862,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Androstane derivatives with activity as pure or predominantly pure stimulators o2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025
Istaroxime-containing intravenous formulation for the treatment of acute heart f2025
Dematerialized instant lottery ticket system and method2023
17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure2023
17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure2023
17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure2023